Nykode Therapeutics enters multi-target license and collaboration agreement with Regeneron
The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease
The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease
The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues
One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
An effectiveness result of 50 per cent achieved during the peak delta variant Covid-19 wave in India, in a highrisk study population of physicians and healthcare workers, in a hospital environment, provides insights into the efficacy and effectiveness of Covaxin
It is estimated that one-third of our country’s population has some form of these disorders
A first for the Asian market, addressing the health spends needs of over 200 million households.
The week-long campaign received a record 17.691 pledges
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
The approval is for Cytomegalovirus, a type of Herpes virus
Subscribe To Our Newsletter & Stay Updated